The results and side effects of systemic isotretinoin treatment in 100 patients with acne vulgaris.
Kaymak
Yesim
Y
University of Gazi Medical Health Center, Ankara, Turkey.
Ilter
Nilsel
N
D000152:Acne Vulgaris / Q000145:classification / Q000188:drug therapy* / Q000473:pathology; D000284:Administration, Oral; D000328:Adult; D001762:Blepharitis / Q000139:chemically induced; D002613:Cheilitis / Q000139:chemically induced; D003231:Conjunctivitis / Q000139:chemically induced; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D016903:Drug Monitoring; D004844:Epistaxis / Q000139:chemically induced; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced; D007057:Ichthyosis / Q000139:chemically induced; D015474:Isotretinoin / Q000008:administration & dosage / Q000009:adverse effects*; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D010146:Pain / Q000139:chemically induced; D011537:Pruritus / Q000139:chemically induced; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014987:Xerostomia / Q000139:chemically induced
D003879:Dermatologic Agents; D007641:Keratolytic Agents; D015474:Isotretinoin